Search Result "phosphatidylinositol 3' kinase"
PfRIO-2 Kinase is a Potential Therapeutic Target of Antimalarial Protein Kinase Inhibitors
Journal: Current Drug Discovery Technologies
Volume: 10 Issue: 1 Year: 2013 Page: 85-91
Author(s): Swagata Nag, KMN Prasad, Ananya Bhowmick, Rohitas Deshmukh, Vishal Trivedi
PI3K Signaling Pathways as a Molecular Target for GlioblastomaMultiforme
Journal: Current Protein & Peptide Science
Volume: 25 Issue: 1 Year: 2024 Page: 12-26
Author(s): Andressa LetÃcia Lopes da Silva,Thiago Pina Goes de Araújo,Shakira Cavalcante de Albuquerque Ferreira,Ana Rachel Vasconcelos de Lima,Anderson Brandão Leite,João Kaycke Sarmento da Silva,Lilyana Waleska Nunes Albuquerque,Leandro Rocha Silva,Edeildo Ferreira da Silva-Júnior,Vivaldo Moura Neto,João Xavier de Araújo-Júnior,Aline Cavalcanti de Queiroz,Magna Suzana Alexandre-Moreira
In silico Approaches to Tyrosine Kinase Inhibitorsâ Development
Ebook: Marvels of Artificial and Computational Intelligence in Life Sciences
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815136807123010014
Neurotrophin-3 Rescues Striatal Synaptic Plasticity in Model ofNeurodegeneration by PLC Signaling Activation
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 23 Issue: 12 Year: 2024 Page: 1488-1498
Author(s): Victor G. Gómez-Pineda,Francisco M. Torres-Cruz
Fungal Metabolites as Potent Protein Kinase Inhibitors: Identification of a Novel Metabolite and Novel Activities of Known Metabolites
Journal: Letters in Drug Design & Discovery
Volume: 1 Issue: 1 Year: 2004 Page: 24-29
Author(s): Masayoshi Oyama, Zhihong Xu, Kuo-Hsiung Lee, Timothy D. Spitzer, Peter Kitrinos, Octerloney B. McDonald, Rosie R.J. Jones, Edward P. Garvey
Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinsonâs and Alzheimerâs Diseases
Journal: Current Gene Therapy
Volume: 18 Issue: 1 Year: 2018 Page: 45-63
Author(s): Alireza Mohammadi,Vahid Ghasem Amooeian,Ehsan Rashidi
Anti-Angiogenic Therapies in the Treatment of Waldenstroms Macroglobulinemia
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 9 Year: 2011 Page: 1025-1029
Author(s): A. Sacco, I. M. Ghobrial, A. M. Roccaro
Molecular Mechanisms Involving Sigma-1 Receptor in Cell Apoptosis of BV-2 Microglial Cells Induced by Methamphetamine
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15 Issue: 7 Year: 2016 Page: 857-865
Author(s): Kai Shen,Yuan Zhang,Xuan Lv,Xufeng Chen,Rongbin Zhou,Lan K. Nguyen,Xiaodong Wu,Honghong Yao
Perspectives on mTOR Inhibitors for Castration-Refractory Prostate Cancer
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 8 Year: 2012 Page: 940-949
Author(s): Salvatore L. Burgio,Francesco Fabbri,Ian J. Seymour,Wainer Zoli,Dino Amadori,Ugo De Giorgi
Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Modelsand Multiple Sclerosis
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 6 Year: 2022 Page: 437-444
Author(s): Anja Steinmaurer,Isabella Wimmer,Thomas Berger,Paulus S Rommer,Johann Sellner